Cell & Tissue Preservation Market: Introduction
According to the report, the global cell & tissue preservation market was valued at US$ 2.95 Bn in 2020. It is projected to expand at a CAGR of 11.9% from 2021 to 2031. Cell & tissue preservation must be maintained at appropriate temperatures to preserve integrity of the tissue. The receiving facility is responsible for maintaining records; documenting that allograft tissue is maintained at adequate environmental requirements during transportation and stored as per the manufacturer's recommendations for the specific tissue.
The current methods of cell & tissue preservation involve freeze-drying, deep-freezing, and cryopreservation. Each of these techniques could be utilized for storage of ligament and meniscal allografts. Deep-freezing is a highly common preservation method for ligament and meniscal allografts, entailing simply freezing the tissue to -80C. The grafts could be preserved for 3 to 5 years. In the freeze-drying process, moisture is removed from the tissue and the graft is vacuum packaged.
It could be stored at room temperature for 3 to 5 years; however, it requires rehydration before implantation. Deep-freezing and freeze-drying allograft tissue reduces immunogenicity by killing antigen-bearing cells. Cryopreservation is a process of controlled-rate freezing with extraction of cellular water by means of glycerol and dimethyl sulfoxide. This process preserves some cells and provides a 10-year shelf life.
Read Report Overview @ https://www.transparencymarketresearch.com/cell-tissue-preservation-market.html
Increase in Healthcare Expenditure
The increase in healthcare expenditure is estimated to further allow access to quality healthcare and advanced products that include biopreservation facilities, thereby broadening growth prospects. Additionally, gene banks, hospitals, and biobanks that are significant end users of the market, are encouraging most players to develop technologically advanced biopreservation products to enhance patient outcomes. The presence of government healthcare initiatives that provide funds, grants, and contracts for research has fueled R&D activities deployed by various companies. This, in turn, has boosted the scope for adoption of advanced bio-preservation services, which, in turn, is anticipated to fuel the penetration rate during the forecast period.
Rising R&D investments by companies and research communities to improve their capabilities and render efficient products & services are estimated to further create opportunities. For instance, the establishment of the Cooperative Human Tissue Network (CHTN), which addressed the operational dimension of bio-banking, exemplifies consistent efforts by the research community.
Get Customization Research on this Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=82712
Tissues to Lead Cell & Tissue Preservation Market
In terms of type, the global cell & tissue preservation market has been classified into cells & tissues. Cells have been split into mammalian cells and others (microorganisms and plant cells). The tissues segment has been split into blood, bone, soft tissues, skin, and others. The tissues segment accounted for 47.6% share of the market in 2020. The segment is anticipated to expand at a CAGR of 11.7% from 2021 to 2031.
Rising investments in the field of regenerative medicine research is projected to boost the cell & tissue preservation market. The knowledge of human cells and tissues being used for further research and development novel treatment therapies led to the introduction of bio banking. Collection, processing, and storage of the samples and the regarding data are the basic function of biobanks.
Therapeutics to Dominate Cell & Tissue Preservation Market
Based on application, the global cell & tissue preservation market has been categorized into therapeutics, research & development, drug discovery, and others. The therapeutics segment accounted for 40.1% share of the cell & tissue preservation market in 2020. The segment is projected to expand at a CAGR of 11.8% from 2021 to 2031. Clinical/therapeutic applications majorly utilize tissue banking, as it involves different types of grafting such as cord blood, stem cell, and others.
Get Discount on the Latest Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=82712
Equipment to be Highly Lucrative Segment
In terms of product, the global cell & tissue preservation market has been divided into equipment, bio preservation media, and software. The equipment segment has been further sub-segmented into freezers, thawing equipment, refrigerators, storage systems, and others. The bio preservation media segment has been further bifurcated into home-brew media and pre-formulated media. The equipment segment was valued at US$ 2,026.1 Mn in 2020 and is projected to reach US$ 6,805.9 Mn in 2031, expanding at a CAGR of 11.8% from 2021 to 2031. This can be attributed to an increase in the demand for biobanks for the past few years and its extensive usage in DNA, plasma, stem cell, and tissue research.
Biobanks to be Key End User
Based on end user, the global cell & tissue preservation market has been divided into biobanks, hospitals & others. The biobanks segment accounted for 68.7% share of the market in 2020. The segment is projected to gain market share marginally to reach 70.5% in 2031. This can be attributed to the growing awareness among researchers about the benefits of stem cells preservation. Furthermore, increasing number of sperm & egg banks and adoption of assisted reproductive technology in animals are key factors estimated to fuel the cell & tissue preservation market growth.
Make an Enquiry before Buying @ https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=82712
North America to Lead Cell & Tissue Preservation Market
In terms of region, the global cell & tissue preservation market has been divided into North America, Europe, Latin America, Asia Pacific, and Middle East & Africa. North America is projected to be a highly attractive market and exhibit an attractiveness index of 2.0 during the forecast period. The market in the region is anticipated to expand at a higher CAGR from 2021 to 2031, owing to consistent drug developments as well as advent of advanced therapies in the field of biomedical research.
A significant rise in patient base requiring high-end treatment of chronic diseases is also responsible for the high demand for biopreservation products and services across the region. Major pharmaceutical companies are engaged in the commercialization of advanced preservation equipment and their subsequent adoption in the research community.
Competition Landscape
The global cell & tissue preservation market is fragmented due to the presence of a large number of prominent players. Key players operating in the global cell & tissue market include Thermo Fisher Scientific, Inc., Lonza, BD, Merck KGaA, Cytiva, Agilent Technologies, Inc., Avantor, Inc., FUJIFILM Irvine Scientific, BioLifeSolutions Inc., AMSBIO, Princeton CryoTech, STEMCELL Technologies Inc., LGC SeraCare, Corning Incorporated, and CellGenix GmbH.
Contact
Rohit BhiseyTransparency Market Research Inc.CORPORATE HEADQUARTER DOWNTOWN,1000 N. West Street,Suite 1200, Wilmington, Delaware 19801 USATel: +1-518-618-1030USA - Canada Toll Free: 866-552-3453Website: https://www.transparencymarketresearch.comBlog: https://tmrblog.comEmail: sales@transparencymarketresearch.com
About Us
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyze information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit subscribe for Future Update - https://www.youtube.com/channel/UC8e-z-g23-TdDMuODiL8BKQ
This release was published on openPR.
More:
Cell & Tissue Preservation Market Size will Observe Lucrative Surge by the End 2031 - openPR
- Japan Stem Cells Market to be at Forefront by 2028 - November 24th, 2022
- Mice Model Technologies Market Outlook, Competitive Landscape and Forecasts to 2031 - openPR - October 13th, 2022
- PRP and PRF in Cosmetics Market Growth Opportunities Analysis Report - openPR - October 13th, 2022
- Orthobiologics Market to Receive Overwhelming Hike in Revenues by 2031 - openPR - October 13th, 2022
- Stem Cells Market is Expected to Grow with High Probability Business Opportunity by 2028 - Digital Journal - October 4th, 2022
- External Beam Radiation Therapy Market: Growing Awareness about Early Detection and Diagnosis of various Cancer Types to Drive the Market - BioSpace - September 16th, 2022
- DiMethyl Sulfoxide (DMSO) Market to Touch US$ 838.6 Million in 2032 Owing to its Widespread Application in End-Use Industries & Anti-Inflammatory... - September 16th, 2022
- Virology Market Growth Prospects, Trends and Forecast up to 2030 - BioSpace - September 8th, 2022
- Cell Banking Outsourcing Market is Driven by Rising Number of Stem Cell Therapies across the Globe - BioSpace - September 8th, 2022
- Regenerative Therapies Market 2018 By Emerging Trends, Industry Share, Regional Overview and SWOT Analysis till 2026 - Digital Journal - August 22nd, 2022
- Autologous Stem Cell and Non-Stem Cell Based Therapies Market Trends, Competitive Landscape and Regional Insights to 2031 - BioSpace - August 14th, 2022
- Multiphoton Microscopy Market Insights, New Innovations, Research and Growth Factor till 2031 - BioSpace - August 14th, 2022
- Buffalo center fuels research that can save your life from heart disease and stroke - Buffalo News - August 5th, 2022
- Drug Discovery Services Market is Expected to Witness Significant Growth between 20212031 - BioSpace - July 27th, 2022
- Stem Cells Market to Expand at a CAGR of 10.4% from 2021 to 2028 Travel Adventure Cinema - Travel Adventure Cinema - July 27th, 2022
- Dental Membrane and Bone Graft Substitutes Market to Exceed Value of US$ 1,337 Mn by 2031 - PR Newswire UK - July 27th, 2022
- Lipid Disorder Treatment Market is Projected to Experience Promising Growth Opportunities in the Forthcoming Years - BioSpace - July 27th, 2022
- Immunoglobin Products Market to Witness Comprehensive Growth by 2031 - BioSpace - July 19th, 2022
- Antibody Therapy Market Propels at a Robust CAGR of 13.2% due to Rising Cancer and Other Chronic Disease Prevalence Future Market Insights, Inc. -... - July 19th, 2022
- Orthobiologics Market is Predicted to Expand at a CAGR of 4.7% during the Forecast Period, notes TMR Study - GlobeNewswire - July 11th, 2022
- Cell Line Development Market: Increase in Prevalence of Cancer and Other Chronic Diseases to Drive the Market - BioSpace - July 11th, 2022
- Transplant Diagnostic Market: Increase in Number of Cancer & Blood Disorder Patients to Drive the Market - BioSpace - July 11th, 2022
- Microscopy Devices Market Competitive Insights and Precise Outlook 2021-2028 Industrial IT - Industrial IT - June 4th, 2022
- Neoantigen Targeted Therapies Market Analysis and Opportunity Assessment up to 2027 - BioSpace - June 4th, 2022
- Why Eraser Enzymes Go Wrong and Lead to Cancer - SciTechDaily - December 10th, 2021
- MorphoSys and Incyte Announce the European Commission Approval of Minjuvi(R) (tafasitamab) in Combination with Lenalidomide for the Treatment of... - August 31st, 2021
- Incyte and MorphoSys Announce the European Commission Approval of Minjuvi (tafasitamab) in Combination With Lenalidomide for the Treatment of Adults... - August 31st, 2021
- Rock snot discovered in another Pennsylvania waterway - pennlive.com - September 12th, 2020
- Bone Marrow and Stem Cell Transplants ChristianaCare - June 20th, 2020
- 'Billion Dollar Burger' Asks: What Is Meat? - Delaware First Media - June 17th, 2020
- Data from Incytes Oncology Portfolio Accepted for Presentation at the ASCO and EHA Virtual Meetings - Yahoo Finance - May 20th, 2020
- Stem Cell therapy Middletown Delaware 19709 - February 10th, 2020
- First CAR-T cell cancer therapy patient in Delaware - Dover Post - February 10th, 2020
- Gore, Mayo Clinic team up to deliver breakthrough medical therapies - Plastics Today - December 17th, 2019
- Global Stem Cell Therapy Market 2019-2025 Analyzed by Business Growth, Development Factors, Applications, and Future Prospects - Technology Magazine - December 17th, 2019
- From inspiration to innovation | UDaily - UDaily - November 14th, 2019
- What Will Happen to Actinium Pharmaceuticals Inc (delaware (NYSEAMERICAN:ATNM) Next? The Stock Has Increase in Shorts - The Lamp News - October 26th, 2019
- Could Fate Therapeutics, Inc. (FATE) Recover After Forming a Bearish Head & Shoulders Pattern? - The Altcoin Mercury - September 25th, 2019
- Stem Cell therapy Lewes Delaware 19958 - September 14th, 2019
- Westfield High School Principal Derrick Nelson was 'gift ... - May 16th, 2019
- SignalRx - March 22nd, 2019
- Stem Cell therapy Newark Delaware 19725 - February 27th, 2019
- Stem Cell therapy Wilmington Delaware 19810 - February 27th, 2019
- Stem Cell Therapy | Regenerative Delaware - February 22nd, 2019
- Regenerative Cell Treatment &Therapy - Delaware ... - February 22nd, 2019
- Stem Cell Doctors Delaware, Stem cell injections, Stem ... - October 14th, 2018
- Regenerative Cell Therapy - Delaware Integrative Medicine - June 22nd, 2018
- FDA Cracks Down On Stem-Cell Clinics Selling Unapproved Treatments - Delaware First Media - August 30th, 2017
- Detroit Lions' Paul Worrilow has beaten odds, inspires others to help - Detroit Free Press - July 2nd, 2017
- Lions LB Paul Worrilow Making A Difference On And Off The Field - FanRag Sports (blog) - July 2nd, 2017
- Lions LB Paul Worrilow gave stem cells to anonymous leukemia patient - Detroit Free Press - March 11th, 2017
- Delaware (Stem Cell) - what-when-how - November 3rd, 2016
- University of Delaware Chemical Engineering - October 31st, 2015
- Home | www.papoutsakis.org - October 4th, 2015
- Stem Cells - Eppendorf - October 2nd, 2015
- Efficient Differentiation of Mouse Embryonic Stem Cells ... - October 1st, 2015
- Alpine Rose Leaf Extract for Environmental Protection for ... - October 1st, 2015
- De-Differentiation of Somatic Cells to a Pluripotent State ... - June 29th, 2015
- DSU AgDiscovery 2015 - Investing in the Future of American ... - June 1st, 2015
- Stem-cell battles: Stem-cell research in the USA is facing ... - April 9th, 2015
- IPS Stem Cells: New Ethical Quandaries - Santa Clara ... - December 27th, 2014
- The California Cloning and Stem Cell Laws - December 27th, 2014
- Can a bodys own stem cells help heal a heart? - October 19th, 2014
- Delaware Stem Cell Treatment | Stem Cell Treatments - September 9th, 2014
- Core mechanism for root growth identified - August 25th, 2014
- Stem Cell Companies - A Comprehensive Overview - August 23rd, 2014
- Stem Cell Doctors, Physician Team, Our Doctors - August 23rd, 2014
- California Stem Cell Report: California Stem Cell Agency ... - August 23rd, 2014
- Bone Marrow and Stem Cell Transplants - Christiana Care ... - August 22nd, 2014